Johnson & Johnson JNJ Income Statement (2009-2026)

NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Johnson & Johnson Quarterly Income Statement

Periods 70 quarters
Latest Jun 2026

Johnson & Johnson reported revenue of $25.31B and net income of $5.53B for the quarter ended Jun 2026, up 6.6% year over year. This income statement covers 70 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2009 Jun2009 Sep2009 Jan2010 Apr2010 Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Dec2017 Apr2018 Jul2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
23.34B19.84B20.21B20.00B19.94B20.89B21.52B21.35B21.39B21.38B22.45B22.47B22.52B21.89B23.74B23.99B24.56B24.06B25.31B
Cost of RevenueCost of Rev
7.25B7.60B7.92B6.17B2.70B6.69B6.46B6.61B6.80B6.51B6.87B6.96B7.13B7.36B7.63B7.30B7.97B8.11B8.05B
Gross Profit
16.09B13.82B13.89B13.82B13.86B14.21B15.06B14.74B14.60B14.87B15.58B15.51B15.39B14.54B16.11B16.69B16.60B15.96B17.26B
Operating items
Research & DevelopmentR&D
3.42B6.15B3.46B3.70B3.48B4.14B3.46B3.70B3.45B4.48B3.54B3.44B4.95B5.30B3.23B3.52B3.67B4.25B3.53B3.65B
Selling, General & AdministrativeSG&A
6.00B5.94B6.23B4.97B2.74B4.91B5.40B5.40B5.81B5.26B5.68B5.48B6.45B5.11B5.89B5.92B6.75B6.03B6.43B
Restructuring CostsRestructuring
0.06B0.07B0.09B0.07B0.11B0.13B0.14B0.16B0.06B0.16B-0.01B0.04B0.04B0.02B0.06B0.06B0.08B0.03B0.03B
Operating ExpensesOpex
9.48B6.15B9.47B10.01B8.53B6.99B8.49B9.24B9.01B10.35B8.96B9.11B10.47B11.79B8.35B9.47B9.66B11.09B9.59B10.12B
Operating IncomeOp. Inc
6.61B4.35B3.88B5.30B6.87B5.72B5.81B5.74B4.25B5.91B6.47B5.04B3.60B6.18B6.65B7.03B5.51B6.36B7.14B
EBIT
6.61B4.35B3.88B5.30B6.87B5.72B5.81B5.74B4.25B5.91B6.47B5.04B3.60B6.18B6.65B7.03B5.51B6.36B7.14B
Non-operating items
Non Operating Interest Expenses
0.02B0.01B0.04B0.05B0.15B0.21B0.22B0.19B0.15B0.15B0.27B0.19B0.14B0.20B0.31B0.24B0.21B0.27B0.28B
Interest & Investment IncomeInt & Inv Inc
0.01B0.02B0.06B0.15B0.45B0.20B0.33B0.37B0.36B0.36B0.40B0.29B0.28B0.33B0.26B0.23B0.24B0.23B0.22B
Other Non Operating IncomeOther Non Op Inc.
-1.85B0.10B-0.27B-0.23B-0.33B-6.94B0.38B-0.50B0.42B-2.40B-0.65B-1.80B0.16B7.32B-0.11B0.48B-0.48B-0.29B-0.33B
Net income details
EBT
3.85B5.20B5.14B5.17B3.84B-1.29B6.31B5.22B4.83B3.71B5.75B3.34B3.89B13.63B6.49B7.49B4.97B5.99B6.75B
Tax ProvisionsTaxes
0.18B0.71B1.03B0.86B1.19B-0.80B0.93B0.91B0.69B0.46B1.06B0.64B0.46B2.63B0.95B2.34B-0.15B0.76B1.21B
Profit After TaxPAT
3.67B5.15B4.81B4.46B3.52B-0.49B5.38B26.03B4.13B3.25B4.69B2.69B3.43B11.00B5.54B5.15B5.12B5.24B5.53B
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
3.67B4.49B4.12B4.31B2.65B-0.49B5.38B4.31B4.13B3.25B4.69B2.69B3.43B11.00B5.54B5.15B5.12B5.24B5.53B
Income from Discontinued OperationsIncome (Discontinued)
0.58B0.55B0.15B0.29B0.42B-0.23B21.72B-0.08B
Consolidated Net IncomeConsol Net Inc.
3.67B5.07B4.67B4.46B2.94B-0.07B5.14B26.03B4.05B3.25B4.69B2.69B3.43B11.00B5.54B5.15B5.12B5.24B5.53B
Income towards Parent CompanyParent Net Inc
3.67B5.07B4.67B4.46B2.94B-0.07B5.14B26.03B4.05B3.25B4.69B2.69B3.43B11.00B5.54B5.15B5.12B5.24B5.53B
Net Income towards Common StockholdersNet Income
3.67B5.07B4.67B4.46B2.94B-0.07B5.14B26.03B4.05B3.25B4.69B2.69B3.43B11.00B5.54B5.15B5.12B5.24B5.53B
Additional items
EPS (Basic)
1.391.931.781.701.12-0.031.9810.321.601.351.951.121.434.572.302.142.132.172.30
EPS (Diluted)
1.371.901.751.681.10-0.031.9610.211.581.341.931.111.414.542.292.122.112.142.27
Shares Outstanding
2.63B2.63B2.63B2.63B2.63B2.63B2.61B2.60B2.52B2.53B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
2.67B2.67B2.67B2.67B2.66B2.66B2.61B2.63B2.55B2.56B2.43B2.42B2.43B2.43B2.42B2.42B2.43B2.43B2.45B2.44B
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.63B2.63B2.63B2.63B2.61B2.60B2.60B2.60B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B2.41B
EBITDA
6.61B4.35B3.88B5.30B6.87B5.72B5.81B5.74B4.25B5.91B6.47B5.04B3.60B6.18B6.65B7.03B5.51B6.36B7.14B
Interest ExpensesInt Expense
0.02B0.01B0.04B0.05B0.15B0.21B0.22B0.19B0.15B0.15B0.27B0.19B0.14B0.20B0.31B0.24B0.21B0.27B0.28B
Tax Rate
4.73%13.70%19.95%16.67%31.02%61.85%14.75%17.40%14.38%12.36%18.48%19.29%11.73%19.31%14.70%31.24%-3.02%12.60%17.98%